Parexel International Corp., a contract research organization based in Waltham, said Thursday that it has been chosen by the Korea Drug Development Fund to help Korean biopharmaceutical companies develop and commercialize health care products for the global market.

A goal of the alliance is to establish collaborative channels that provide essential resources to Korean research institutions and biopharmaceutical companies.

Waltham-based Parexel said has more than 2,800 employees and 21 offices throughout the Asia-Pacific region.